These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 9439824)

  • 1. Contribution of somal Lewy bodies to neuronal death.
    Tompkins MM; Hill WD
    Brain Res; 1997 Nov; 775(1-2):24-9. PubMed ID: 9439824
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Apoptotic-like changes in Lewy-body-associated disorders and normal aging in substantia nigral neurons.
    Tompkins MM; Basgall EJ; Zamrini E; Hill WD
    Am J Pathol; 1997 Jan; 150(1):119-31. PubMed ID: 9006329
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neurofilament mRNA is reduced in Parkinson's disease substantia nigra pars compacta neurons.
    Hill WD; Arai M; Cohen JA; Trojanowski JQ
    J Comp Neurol; 1993 Mar; 329(3):328-36. PubMed ID: 8459049
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Purification and characterization of Lewy bodies from the brains of patients with diffuse Lewy body disease.
    Iwatsubo T; Yamaguchi H; Fujimuro M; Yokosawa H; Ihara Y; Trojanowski JQ; Lee VM
    Am J Pathol; 1996 May; 148(5):1517-29. PubMed ID: 8623921
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Convergence of Lewy bodies and neurofibrillary tangles in amygdala neurons of Alzheimer's disease and Lewy body disorders.
    Schmidt ML; Martin JA; Lee VM; Trojanowski JQ
    Acta Neuropathol; 1996; 91(5):475-81. PubMed ID: 8740227
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Parkin localizes to the Lewy bodies of Parkinson disease and dementia with Lewy bodies.
    Schlossmacher MG; Frosch MP; Gai WP; Medina M; Sharma N; Forno L; Ochiishi T; Shimura H; Sharon R; Hattori N; Langston JW; Mizuno Y; Hyman BT; Selkoe DJ; Kosik KS
    Am J Pathol; 2002 May; 160(5):1655-67. PubMed ID: 12000718
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Active, phosphorylation-dependent mitogen-activated protein kinase (MAPK/ERK), stress-activated protein kinase/c-Jun N-terminal kinase (SAPK/JNK), and p38 kinase expression in Parkinson's disease and Dementia with Lewy bodies.
    Ferrer I; Blanco R; Carmona M; Puig B; Barrachina M; Gómez C; Ambrosio S
    J Neural Transm (Vienna); 2001; 108(12):1383-96. PubMed ID: 11810403
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pathological changes in dendrites of substantia nigra neurons in Parkinson's disease: a Golgi study.
    Patt S; Gertz HJ; Gerhard L; Cervós-Navarro J
    Histol Histopathol; 1991 Jul; 6(3):373-80. PubMed ID: 1725760
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fatal attractions: abnormal protein aggregation and neuron death in Parkinson's disease and Lewy body dementia.
    Trojanowski JQ; Goedert M; Iwatsubo T; Lee VM
    Cell Death Differ; 1998 Oct; 5(10):832-7. PubMed ID: 10203692
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Incidental occurrence of Lewy bodies in the brains of elderly patients--the relevance to aging and Parkinson's disease].
    Wakabayashi K; Takahashi H; Oyanagi K; Ikuta F
    No To Shinkei; 1993 Nov; 45(11):1033-8. PubMed ID: 8135950
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Developmental cell death in dopaminergic neurons of the substantia nigra of mice.
    Jackson-Lewis V; Vila M; Djaldetti R; Guegan C; Liberatore G; Liu J; O'Malley KL; Burke RE; Przedborski S
    J Comp Neurol; 2000 Aug; 424(3):476-88. PubMed ID: 10906714
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The frequency of Lewy bodies in a consecutive autopsy series.
    Lindboe CF; Hansen HB
    Clin Neuropathol; 1998; 17(4):204-9. PubMed ID: 9707335
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stability of cell size and nucleolar size in Lewy body containing neurons of substantia nigra in Parkinson's disease.
    Gertz HJ; Siegers A; Kuchinke J
    Brain Res; 1994 Feb; 637(1-2):339-41. PubMed ID: 8180816
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Colocalization of tau and alpha-synuclein epitopes in Lewy bodies.
    Ishizawa T; Mattila P; Davies P; Wang D; Dickson DW
    J Neuropathol Exp Neurol; 2003 Apr; 62(4):389-97. PubMed ID: 12722831
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gene expression profiling of Lewy body-bearing neurons in Parkinson's disease.
    Lu L; Neff F; Alvarez-Fischer D; Henze C; Xie Y; Oertel WH; Schlegel J; Hartmann A
    Exp Neurol; 2005 Sep; 195(1):27-39. PubMed ID: 15944136
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Two types of spheroid bodies in the nigral neurons in Parkinson's disease.
    Yamada T; Akiyama H; McGeer PL
    Can J Neurol Sci; 1991 Aug; 18(3):287-94. PubMed ID: 1913362
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cellular co-localization of phosphorylated tau- and NACP/alpha-synuclein-epitopes in lewy bodies in sporadic Parkinson's disease and in dementia with Lewy bodies.
    Arima K; Hirai S; Sunohara N; Aoto K; Izumiyama Y; Uéda K; Ikeda K; Kawai M
    Brain Res; 1999 Oct; 843(1-2):53-61. PubMed ID: 10528110
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alpha-synuclein redistributes to neuromelanin lipid in the substantia nigra early in Parkinson's disease.
    Halliday GM; Ophof A; Broe M; Jensen PH; Kettle E; Fedorow H; Cartwright MI; Griffiths FM; Shepherd CE; Double KL
    Brain; 2005 Nov; 128(Pt 11):2654-64. PubMed ID: 16000336
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lewy Bodies: A Spectator or Salient Killer?
    Sian-Hulsmann J; Monoranu C; Strobel S; Riederer P
    CNS Neurol Disord Drug Targets; 2015; 14(7):947-55. PubMed ID: 25801839
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multicatalytic proteinase is associated with characteristic oval structures in cortical Lewy bodies: an immunocytochemical study with light and electron microscopy.
    Masaki T; Ishiura S; Sugita H; Kwak S
    J Neurol Sci; 1994 Apr; 122(2):127-34. PubMed ID: 8021694
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.